v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating Expenses [Abstract]    
Research and development $ 16,567,000 $ 7,755,000
General and administrative 5,897,000 2,715,000
Total operating expenses 22,464,000 10,470,000
Loss from operations (22,464,000) (10,470,000)
Other income (expense), net:    
Unrealized loss on short-term investments (13,000) (15,000)
Interest and dividend income 889,000 1,175,000
Total other income, net 876,000 1,160,000
Net loss $ (21,588,000) $ (9,310,000)
Net loss per share of common stock, basic $ (0.99) $ (0.71)
Net loss per share of common stock, diluted $ (0.99) $ (0.71)
Weighted-average shares used in net loss per share calculation, basic 21,815,995 13,194,718
Weighted-average shares used in net loss per share calculation, diluted 21,815,995 13,194,718
Comprehensive income (loss):    
Net loss $ (21,588,000) $ (9,310,000)
Unrealized (loss) gain on short-term investments (67,000) 44,000
Comprehensive loss $ (21,655,000) $ (9,266,000)